Here's Why Inovio Pharmaceuticals Inc. Fell 21.3% in November

Here's Why Inovio Pharmaceuticals Inc. Fell 21.3% in November

Shares of Inovio Pharmaceuticals Inc. (NASDAQ: INO), a biopharmaceutical company developing vaccines, fell 21.3% in November according to data from S&P Global Market Intelligence. Despite reporting some important pipeline progress investors weren't pleased with the company's widening losses.

Inovio Pharmaceuticals Inc.'s third-quarter loss grew 64% to $34.1 million from $20.8 million last year. Without product sales to smooth out the bumps, Inovio's top line is prone to exceptional lumpiness from one quarter to the next as it recognizes various one-time cash infusions from collaboration partners.

Image source: Getty Images.

Continue reading

Source: Fool.com